XM n’offre pas ses services aux résidents des États-Unis d’Amérique.
H
H

Hologic


Actualités

U.S. Hubspot, McDonald's, Tesla

U.S. RESEARCH ROUNDUP- Hubspot, McDonald's, Tesla July 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Hubspot, McDonald's and Tesla, on Tuesday. HIGHLIGHTS * Ameriprise Financial Inc AMP.N : KBW cuts target price to $460 from $470 * First Citizens Bancshares FCNCA.O : Jefferies raises target price to $2,460 from $2,005 * Hubspot Inc HUBS.N : TD Cowen cuts target price to $600 from $680 * McDonald's MCD.N : Piper
A
H
A
D
L
A
A
B

Hologic quarterly profit rises on strong demand for its women's health products

Hologic quarterly profit rises on strong demand for its women's health products July 29 (Reuters) - Medical technology company Hologic HOLX.O reported a higher third-quarter profit on Monday, driven by strong demand for its diagnostics and breast health products, but forecast revenue for the current quarter that fell short of Wall Street estimates.
H

Hologic Inc reports results for the quarter ended in June - Earnings Summary

Hologic Inc reports results for the quarter ended in June - Earnings Summary Hologic Inc HOLX.OQ reported quarterly adjusted earnings of $1.06​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of 93 cents. The mean expectation of sixteen analysts for the quarter was for earnings of $1.02 per share.
H

Hologic Q3 Adjusted EBITDA USD 338.5 Million Vs. IBES Estimate USD 333.4 Million

BRIEF-Hologic Q3 Adjusted EBITDA USD 338.5 Million Vs. IBES Estimate USD 333.4 Million Jul 29 (Reuters) - Hologic Q3 adjusted net income USD 250.7 million vs. IBES estimate USD 240.7 million. Q3 net income USD 194.5 million Q3 operating margin 24.1% Q3 adjusted operating margin 31.2% Q3 adjusted gross margin 61.1% Q3 gross margin 55.4% Q3 revenue USD 1,011.4 million vs.
H

Hologic Inc <HOLX.OQ> expected to post earnings of $1.02 a share - Earnings Preview

Hologic Inc expected to post earnings of $1.02 a share - Earnings Preview Hologic Inc HOLX.OQ HOLX.O is expected to show a rise in quarterly revenue when it reports results on July 29 for the period ending June 30 2024 The Marlborough Massachusetts-based company is expected to report a 1.6% increase in revenue to $1 billion from $984.4 million a year ago, according to the mean estimate from 14 analysts, based on LSEG data.The company's guidance on May 2 2024, for the period ended June 30, was fo
H

Hologic Completes Acquisition Of Endomagnetics Ltd

BRIEF-Hologic Completes Acquisition Of Endomagnetics Ltd July 25 (Reuters) - Hologic Inc HOLX.O : HOLOGIC COMPLETES ACQUISITION OF ENDOMAGNETICS LTD Source text for Eikon: ID:nBw5Dy4qTa Further company coverage: HOLX.O
H

U.S. Colgate-Palmolive, McKesson, Microsoft

U.S. RESEARCH ROUNDUP-Colgate-Palmolive, McKesson, Microsoft July 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Colgate-Palmolive, McKesson and Microsoft, on Tuesday. HIGHLIGHTS * Colgate-Palmolive Co CL.N : TD Cowen initiates coverage with buy rating; PT $110 * DR Horton Inc DHI.N : JP Morgan raises target price to $180 from $163 * IQVIA Holdings Inc IQV.N : Baird raises target price to $251 from $235 * McKesso
C
H
M
M
T
V
Z
F
A
M
A
C
C
D
I

U.S. STOCKS Tempus AI, AeroVironment, Gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, AeroVironment, Gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were flat on Thursday, as investors assessed a string of economic data ahead of the Federal Reserve's closely watched inflation report, while Micron and pharmacy chain Walgreens Boots Alliance slumped on disappointing forecasts.
B
G
H
M
N
S
W
U
U
T
C
M

U.S. STOCKS Verona Pharma, McCormick, gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Verona Pharma, McCormick, gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq slightly fell while other indexes were flat to slightly higher on Thursday, as a dip in Treasury yields after a string of economic data boosted megacap stocks.
B
G
H
M
S
W
U
U
T
M

U.S. STOCKS Elanco Animal Health, Levi Strauss, SM Energy

BUZZ-U.S. STOCKS ON THE MOVE-Elanco Animal Health, Levi Strauss, SM Energy Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures slipped on Thursday as a slump in Micron Technology after a lackluster forecast dragged down other semiconductor stocks, while caution ahead of economic data and a presidential debate also dented sentiment.
H
M
W
U
T

U.S. STOCKS International Paper, U.S. Bancorp, Micron Technology

BUZZ-U.S. STOCKS ON THE MOVE-International Paper, U.S. Bancorp, Micron Technology Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures slipped on Thursday as a slump in Micron Technology after a lackluster forecast dragged down other semiconductor stocks, while caution ahead of economic data and a presidential debate also dented sentiment.
H
M
W
U

Stephens starts Hologic with 'overweight' on balance sheet, M&A potential

BUZZ-Stephens starts Hologic with 'overweight' on balance sheet, M&A potential ** Stephens starts Hologic HOLX.O with "overweight", citing the women's health diagnostic equipment maker's strong balance sheet, low leverage ratio and potential for M&A ** Sets TP of $87 vs stock's last close of $72.27; stock flat in premarket trading ** "With leverage
H

U.S. Carnival, FedEx, Micron Technology

U.S. RESEARCH ROUNDUP-Carnival, FedEx, Micron Technology June 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Carnival, FedEx and Micron Technology, on Thursday. HIGHLIGHTS * Carnival Corp CCL.N : Macquarie raises target price to $25 from $24 * FedEx Corp FDX.N : Daiwa Capital Markets raises target price to $318 from $296 * Micron Technology Inc MU.O : JP Morgan raises target price to $180 from $130 * Unifirst Cor
A
E
G
H
H
M
N
S
A
C
C
E

Australia's Lumos Diagnostics jumps on $5 mln payment

BUZZ-Australia's Lumos Diagnostics jumps on $5 mln payment ** Shares of Lumos Diagnostics LDX.AX rise as much as 21.6% to A$0.045, set for its best day since Jan. 11 if gains hold ** Healthcare tech co says it has received a second payment of US$5.0 million from Hologic HOLX.O under the intellectual property (IP) agreement announced on 11 Jan. ** I
H

FDA classifies recall of Hologic's implant as 'most serious'

UPDATE 1-FDA classifies recall of Hologic's implant as 'most serious' Adds detail and background in paragraphs 2 to 6 May 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's HOLX.O devices that are implanted in soft tissue such as breast tissue as "most serious", and urged doctors to more actively monitor for side-effects.
H

FDA classifies recall of Hologic's implants for soft tissue as 'most serious'

FDA classifies recall of Hologic's implants for soft tissue as 'most serious' May 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's HOLX.O devices that are implanted in soft tissue such as breast tissue as "most serious". Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber
H



Conditions

Actifs populaires

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques